Aflibercept, ranibizumab and bevacizumab upcoming biosimilars: a general overview
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:57 |
|---|---|
| Enthalten in: |
Drugs of today - 57(2021), 11, Seite 689 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Viola, P. [VerfasserIn] |
|---|
| Links: |
FID Access [lizenzpflichtig] |
|---|
| Umfang: |
1 Online-Ressource |
|---|
| doi: |
10.1358/dot.2021.57.11.3331006 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
KFL010940901 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | KFL010940901 | ||
| 003 | DE-627 | ||
| 005 | 20230502163720.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230327s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1358/dot.2021.57.11.3331006 |2 doi | |
| 035 | |a (DE-627)KFL010940901 | ||
| 035 | |a (KFL)prod_QApH_3331006 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 084 | |a PHARM |q DE-84 |2 fid | ||
| 100 | 1 | |a Viola, P. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Aflibercept, ranibizumab and bevacizumab upcoming biosimilars: a general overview |
| 264 | 1 | |c 2021 | |
| 300 | |a 1 Online-Ressource | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 700 | 1 | |a Testa, V. |e verfasserin |4 aut | |
| 700 | 1 | |a Ferro Desideri, L. |e verfasserin |4 aut | |
| 700 | 1 | |a Di Cello, L. |e verfasserin |4 aut | |
| 700 | 1 | |a Rutigliani, C. |e verfasserin |4 aut | |
| 700 | 1 | |a Vagge, A. |e verfasserin |4 aut | |
| 700 | 1 | |a Nicolo, M. |e verfasserin |4 aut | |
| 700 | 1 | |a Cian, R. |e verfasserin |4 aut | |
| 700 | 1 | |a Traverso, C.E |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Drugs of today |d [Philadelphia, PA] : Clarivate Analytics, 1998 |g 57(2021), 11, Seite 689 |h Online-Ressource |w (DE-627)KFL000006092 |w (DE-600)2115884-8 |w (DE-576)481527222 |x 1699-4019 |7 nnns |
| 773 | 1 | 8 | |g volume:57 |g year:2021 |g number:11 |g pages:689 |
| 856 | 4 | 0 | |u http://pharmazie.proxy.fid-lizenzen.de/fid/thomson-reuters-ejournals-pharmazie/integrity.clarivate.com/integrity/xmlxsl/pk_ref_list.showUniqueReferenceList?p_id=3331006 |m X:KFL |x Verlag |y FID Access |z lizenzpflichtig |
| 912 | |a ZDB-1-TRE | ||
| 912 | |a GBV_KFL | ||
| 912 | |a FID-PHARM | ||
| 935 | |i IMPORT_0628_prod_QApH_02 | ||
| 951 | |a AR | ||
| 952 | |d 57 |j 2021 |e 11 |h 689 | ||